Bausch Health Companies Inc. (BHC)
USD 7.34
(-4.43%)
USD 7.34
(-4.43%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.88 Billion USD | 11.76% |
| 2022 | 2.62 Billion USD | 0.0% |
| 2021 | 1.93 Billion USD | 2.66% |
| 2020 | 2.55 Billion USD | 38.05% |
| 2019 | 1.89 Billion USD | -42.53% |
| 2018 | 332.15 Million USD | -6.84% |
| 2017 | 3.41 Billion USD | -37.57% |
| 2016 | 2.23 Billion USD | 7.33% |
| 2015 | 5.1 Billion USD | 23.03% |
| 2014 | 3.91 Billion USD | 31.33% |
| 2013 | 865.4 Million USD | 69.0% |
| 2012 | 1.07 Billion USD | 88.39% |
| 2011 | 929.12 Million USD | 93.41% |
| 2010 | 102.54 Million USD | 45.76% |
| 2009 | 349.09 Million USD | -13.41% |
| 2008 | 230.82 Million USD | 5.18% |
| 2007 | 289.45 Million USD | -33.69% |
| 2006 | 349.73 Million USD | 21.93% |
| 2005 | 440.79 Million USD | 37.51% |
| 2004 | 323.59 Million USD | -33.48% |
| 2003 | 272.26 Million USD | -11.51% |
| 2002 | 391.99 Million USD | 35.26% |
| 2001 | 319.5 Million USD | 20.69% |
| 2000 | 151.91 Million USD | 322.44% |
| 1999 | 85.6 Million USD | 57.67% |
| 1998 | 54.1 Million USD | 32.92% |
| 1997 | 40.7 Million USD | 59.61% |
| 1996 | 25.5 Million USD | 12650.0% |
| 1995 | 3.81 Million USD | 105.13% |
| 1994 | 3.56 Million USD | 25.0% |
| 1993 | 500 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 611.25 Million USD | -27.48% |
| 2024 Q2 | 743.84 Million USD | 18.57% |
| 2024 Q3 | 318 Million USD | -10.0% |
| 2023 Q1 | 477 Million USD | -32.82% |
| 2023 Q2 | 741 Million USD | 55.35% |
| 2023 Q3 | 693 Million USD | -6.48% |
| 2023 FY | - USD | 11.76% |
| 2023 Q4 | -3.12 Billion USD | -550.79% |
| 2022 Q2 | 636 Million USD | 2.91% |
| 2022 Q3 | 716 Million USD | 12.58% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | 710 Million USD | -0.84% |
| 2022 Q1 | 618 Million USD | -15.34% |
| 2021 Q4 | 730 Million USD | -8.86% |
| 2021 FY | - USD | 2.66% |
| 2021 Q1 | 767 Million USD | 51.28% |
| 2021 Q3 | 801 Million USD | 317.19% |
| 2021 Q2 | 192 Million USD | -74.97% |
| 2020 Q2 | 430 Million USD | -45.57% |
| 2020 Q4 | 507 Million USD | -40.98% |
| 2020 FY | - USD | 38.05% |
| 2020 Q1 | 790 Million USD | 234.13% |
| 2020 Q3 | 859 Million USD | 99.77% |
| 2019 Q4 | -589 Million USD | -165.52% |
| 2019 Q3 | 899 Million USD | 14.52% |
| 2019 Q2 | 785 Million USD | -4.85% |
| 2019 Q1 | 825 Million USD | 4.17% |
| 2019 FY | - USD | -42.53% |
| 2018 FY | - USD | -6.84% |
| 2018 Q1 | 784 Million USD | 40.25% |
| 2018 Q2 | 843 Million USD | 7.53% |
| 2018 Q3 | 882 Million USD | 4.63% |
| 2018 Q4 | 792 Million USD | -10.2% |
| 2017 Q2 | 882 Million USD | 11.22% |
| 2017 Q3 | 900 Million USD | 2.04% |
| 2017 Q4 | 559 Million USD | -37.89% |
| 2017 FY | - USD | -37.57% |
| 2017 Q1 | 793 Million USD | -28.24% |
| 2016 Q2 | 1.06 Billion USD | 23.99% |
| 2016 FY | - USD | 7.33% |
| 2016 Q4 | 1.1 Billion USD | -49.24% |
| 2016 Q3 | 2.17 Billion USD | 105.08% |
| 2016 Q1 | 856.1 Million USD | -25.13% |
| 2015 FY | - USD | 23.03% |
| 2015 Q4 | 1.14 Billion USD | -16.17% |
| 2015 Q1 | 1.14 Billion USD | 20.3% |
| 2015 Q2 | 1.42 Billion USD | 24.16% |
| 2015 Q3 | 1.36 Billion USD | -4.44% |
| 2014 Q4 | 955.6 Million USD | -10.61% |
| 2014 Q1 | 1.08 Billion USD | 6.55% |
| 2014 Q2 | 1.02 Billion USD | -6.18% |
| 2014 FY | - USD | 31.33% |
| 2014 Q3 | 1.06 Billion USD | 4.76% |
| 2013 Q4 | 1.02 Billion USD | 26.2% |
| 2013 FY | - USD | 69.0% |
| 2013 Q3 | 808.88 Million USD | 52.49% |
| 2013 Q2 | 530.46 Million USD | -7.04% |
| 2013 Q1 | 570.66 Million USD | -16.77% |
| 2012 Q2 | 361.29 Million USD | 8.83% |
| 2012 Q4 | 685.66 Million USD | 114.92% |
| 2012 Q1 | 331.98 Million USD | 31.95% |
| 2012 Q3 | 319.03 Million USD | -11.7% |
| 2012 FY | - USD | 88.39% |
| 2011 Q1 | 228.95 Million USD | 83.0% |
| 2011 Q3 | 275.75 Million USD | -3.29% |
| 2011 Q4 | 251.6 Million USD | -8.76% |
| 2011 FY | - USD | 93.41% |
| 2011 Q2 | 285.14 Million USD | 24.54% |
| 2010 Q3 | 12.06 Million USD | -86.91% |
| 2010 Q2 | 92.16 Million USD | 61.07% |
| 2010 Q4 | 125.1 Million USD | 936.7% |
| 2010 FY | - USD | 45.76% |
| 2010 Q1 | 57.21 Million USD | -47.84% |
| 2009 Q2 | 54.25 Million USD | -33.83% |
| 2009 FY | - USD | -13.41% |
| 2009 Q1 | 81.98 Million USD | -16.24% |
| 2009 Q4 | 109.69 Million USD | 4.81% |
| 2009 Q3 | 104.66 Million USD | 92.91% |
| 2008 FY | - USD | 5.18% |
| 2008 Q4 | 97.88 Million USD | 11.76% |
| 2008 Q3 | 87.58 Million USD | -31.55% |
| 2008 Q2 | 127.96 Million USD | 39.49% |
| 2008 Q1 | 91.73 Million USD | -5.39% |
| 2007 Q1 | 118.68 Million USD | -37.86% |
| 2007 Q2 | 87.78 Million USD | -26.03% |
| 2007 FY | - USD | -33.69% |
| 2007 Q3 | 77.38 Million USD | -11.85% |
| 2007 Q4 | 96.96 Million USD | 25.31% |
| 2006 FY | - USD | 21.93% |
| 2006 Q4 | 191 Million USD | 13.82% |
| 2006 Q3 | 167.8 Million USD | 53.41% |
| 2006 Q2 | 109.38 Million USD | 4.55% |
| 2006 Q1 | 104.62 Million USD | -47.83% |
| 2005 Q3 | 143.14 Million USD | 31.62% |
| 2005 Q4 | 200.55 Million USD | 40.11% |
| 2005 FY | - USD | 37.51% |
| 2005 Q2 | 108.75 Million USD | 173.29% |
| 2005 Q1 | 39.79 Million USD | -60.23% |
| 2004 Q4 | 100.06 Million USD | 15.16% |
| 2004 Q1 | 71.88 Million USD | -31.0% |
| 2004 Q3 | 86.88 Million USD | -0.6% |
| 2004 Q2 | 87.41 Million USD | 21.6% |
| 2004 FY | - USD | -33.48% |
| 2003 Q3 | 84.15 Million USD | -48.83% |
| 2003 FY | - USD | -11.51% |
| 2003 Q1 | 120.99 Million USD | -69.33% |
| 2003 Q4 | -40 Million USD | -4.0% |
| 2003 Q2 | 144.71 Million USD | 121.55% |
| 2002 Q3 | 109.09 Million USD | 12.24% |
| 2002 Q1 | 73.4 Million USD | -62.06% |
| 2002 FY | - USD | 35.26% |
| 2002 Q4 | 114.02 Million USD | 191.34% |
| 2002 Q2 | 95.46 Million USD | 30.07% |
| 2001 Q2 | 74.24 Million USD | 20.25% |
| 2001 FY | - USD | 20.69% |
| 2001 Q1 | 61.74 Million USD | -52.53% |
| 2001 Q4 | 100.76 Million USD | 83.39% |
| 2001 Q3 | 82.74 Million USD | 42.06% |
| 2000 Q4 | 63.14 Million USD | -29.56% |
| 2000 Q3 | 44.96 Million USD | 613.4% |
| 2000 Q1 | 19.76 Million USD | -37.27% |
| 2000 FY | - USD | 322.44% |
| 2000 Q2 | 25.88 Million USD | 30.98% |
| 1999 Q2 | 17.2 Million USD | 30.3% |
| 1999 Q1 | 13.2 Million USD | -27.47% |
| 1999 Q3 | 21.74 Million USD | 36.63% |
| 1999 Q4 | 32.2 Million USD | 34.04% |
| 1999 FY | - USD | 57.67% |
| 1998 Q2 | 11.3 Million USD | 17.71% |
| 1998 Q4 | 18.2 Million USD | 19.74% |
| 1998 FY | - USD | 32.92% |
| 1998 Q1 | 9.6 Million USD | -36.42% |
| 1998 Q3 | 15.2 Million USD | 34.51% |
| 1997 Q3 | 10.8 Million USD | 33.33% |
| 1997 FY | - USD | 59.61% |
| 1997 Q2 | 8.2 Million USD | 22.73% |
| 1997 Q1 | 6.6 Million USD | -2.94% |
| 1997 Q4 | 15.1 Million USD | 39.81% |
| 1996 Q4 | 6.8 Million USD | -1.45% |
| 1996 Q1 | 5.3 Million USD | 162.42% |
| 1996 FY | - USD | 12650.0% |
| 1996 Q2 | 6.35 Million USD | 15.09% |
| 1996 Q3 | 7 Million USD | 13.11% |
| 1995 Q2 | 2.88 Million USD | 69.55% |
| 1995 Q1 | 1.7 Million USD | 118.28% |
| 1995 Q3 | 3.3 Million USD | 14.79% |
| 1995 Q4 | -8.49 Million USD | -356.63% |
| 1995 FY | - USD | 105.13% |
| 1994 Q4 | -9.3 Million USD | -275.47% |
| 1994 Q1 | 2.5 Million USD | 0.0% |
| 1994 Q2 | 1.3 Million USD | -48.0% |
| 1994 Q3 | 5.3 Million USD | 307.69% |
| 1994 FY | - USD | 25.0% |
| 1993 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 500.78 Million USD | -476.099% |
| Catalent, Inc. | -284 Million USD | 1115.845% |
| Emergent BioSolutions Inc. | -505.29 Million USD | 670.948% |
| Elanco Animal Health Incorporated | -224 Million USD | 1387.946% |
| Perrigo Company plc | 646.2 Million USD | -346.456% |
| Teva Pharmaceutical Industries Limited | 4.33 Billion USD | 33.418% |
| Zoetis Inc. | 3.68 Billion USD | 21.71% |